Kate Sheridan is a research reporter at STAT, collecting and analyzing documents, data, and other information for biotech, health tech, science, and politics stories. She joined STAT in 2018 to cover biotech startups and venture capital. Previously, she was a science writer at Newsweek and completed internships at STAT and the Montreal Gazette. Kate graduated from McGill University with a bachelor’s degree in cognitive science in 2014. Currently based in New York, she prefers Montreal’s bagels. To send encrypted messages, please contact her on a non-work device via Signal at 617-475-0364.
